Webinar
Revolutionizing Efficacy and Safety Studies by Combining Organ‑on‑Chip Technology with xMAP‑Based Bio‑Plex Immunoassays

Choose your preferred day and time from the following options:

Americas and European Session

Sept 20
Wed 9:00 AM PDT

Asia Pacific Session

Sept 21
Thu 11:30 AM SST

Join our webinar to explore the cutting‑edge field of 3D cell culture models and their application in the development of therapeutics. Discover how researchers are utilizing the xMAP multiplex immunoassays to monitor biomarkers associated with tubular nephrotoxicity in kidney proximal tubule chips. Learn how this approach saves time and precious samples versus conventional methods by enabling the analysis of multiple targets within a single well. Don't miss this opportunity to delve into the world of 3D cell culture and learn how these model systems will help streamline drug efficacy and safety studies.

In this webinar you will learn how:

  • 3D cell culture models are superior to 2D models in the study of complex biological phenomena
  • Multiplex immunoassays conserve samples and maximize biomarker data for informed decision making
  • The combination of Organ‑on‑Chip and Multiplex technologies enables robust safety and efficacy assessment of drug candidate molecules in preclinical studies
John Williford

John Williford,
Director of Biomanufacturing and Contract Research Nortis

John is the Director of Biomanufacturing and Contract Research. He oversees the Biomanufacturing of Collagen Pre-filled Nortis chips and Pre-seeded chips. He and his team also run custom experiments for clients as part of Contract Services. He has over 30 years of experience in the Biotech industry. John has extensive experience in assay development, microfluidics, and automation. He joined Nortis approximately 3 years ago and it was a perfect mix of his assay development experience and innovation. He has degrees in Biology and Chemistry from Eastern Washington University.

John Williford

Elizabeth Jordan Dreskin, PhD,
R&D Manager, Bio‑Rad Laboratories

Dr. Liz Jordan Dreskin is an R&D Manager at Bio‑Rad Laboratories, where she leads the applications team for the Life Science group. Her team works with marketing to develop data and literature to support the Bio‑Rad catalog of Life Science products. After a post‑doc at University of California, San Francisco (UCSF), Liz joined Bio‑Rad technical support to aid customers in biochemistry and molecular biology‑related techniques. She later moved into R&D where she has held various roles including validation and applications. Liz received her B.A. degree from Mount Holyoke College, and Ph.D. in Biological Chemistry from the University of Michigan.

Vanitha Margan

Vanitha Margan,
Global Product Manager, Bio‑Plex Immunoassays

Vanitha Margan is the Global Product Manager for the Immunoassays team at Bio‑Rad Laboratories. She has held medical laboratory scientist, field application specialist, and sales roles in Malaysia prior to joining Bio‑Rad in 2007. At Bio‑Rad, she has worked in both Clinical Diagnostics and Life Science groups spanning from technical support, sales, regional marketing, and global marketing. Her specialties include clinical chemistry, diabetes monitoring, immunoassays, infectious diseases, inflammation markers, and clinical laboratory quality control. She graduated with a Bachelor of Applied Science from Swinburne University of Technology, Australia with a double major in Biochemistry and Chemistry. She earned her MBA from the University of Phoenix, USA.